American Journal of Obstetrics & Gynecology
Volume 203, Issue 2 , Pages 120.e1-120.e6 , August 2010

Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study

  • Wang Ya, MD

      Affiliations

    • Department of Gynecology, Yuyao/Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
    • ,
  • Cheryl Reifer, PhD

      Affiliations

    • Sprim Advanced Life Sciences, San Francisco, CA
    • ,
  • Larry E. Miller, PhD

      Affiliations

    • Sprim Advanced Life Sciences, San Francisco, CA
    • Corresponding Author InformationReprints: Larry E. Miller, PhD, Sprim Advanced Life Sciences, 235 Pine St., Suite 1175, San Francisco, CA 94104

Received 6 January 2010 ,Revised 19 March 2010 ,Accepted 11 May 2010.

References 

  1. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007;34:864–869
  2. Madhivanan P, Krupp K, Chandrasekaran V, et al. Prevalence and correlates of bacterial vaginosis among young women of reproductive age in Mysore, India. Indian J Med Microbiol. 2008;26:132–137
  3. Bhalla P, Chawla R, Garg S, et al. Prevalence of bacterial vaginosis among women in Delhi, India. Indian J Med Res. 2007;125:167–172
  4. Sodhani P, Garg S, Bhalla P, Singh MM, Sharma S, Gupta S. Prevalence of bacterial vaginosis in a community setting and role of the pap smear in its detection. Acta Cytol. 2005;49:634–638
  5. Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol. 2005;106:1013–1023
  6. Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect. 2007;13:657–664
  7. Klebanoff MA, Schwebke JR, Zhang J, Nansel TR, Yu KF, Andrews WW. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol. 2004;104:267–272
  8. Ness RB, Kip KE, Hillier SL, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol. 2005;162:585–590
  9. Hay PE, Morgan DJ, Ison CA, et al. A longitudinal study of bacterial vaginosis during pregnancy. BJOG. 1994;101:1048–1053
  10. Larsson PG, Bergstrom M, Forsum U, Jacobsson B, Strand A, Wolner-Hanssen P. Bacterial vaginosis: transmission, role in genital tract infection and pregnancy outcome: an enigma. APMIS. 2005;113:233–245
  11. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant: the Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995;333:1737–1742
  12. American College of Obstetricians and Gynecologists Committee on Practice Bulletins: gynecology. Practice bulletin no. 72: Clinical management guidelines for obstetrician-gynecologists: vaginitis. Obstet Gynecol. 2006;107:1195–1206
  13. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006;193:1478–1486
  14. Pirotta M, Fethers KA, Bradshaw CS. Bacterial vaginosis: more questions than answers. Aust Fam Physician. 2009;38:394–397
  15. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health. 2008;8:3
  16. Swidsinski A, Mendling W, Loening-Baucke V, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198:97.e1–97.e6
  17. Nagaraja P. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis. Indian J Med Microbiol. 2008;26:155–157
  18. Marrazzo JM, Cook RL, Wiesenfeld HC, et al. Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J Womens Health (Larchmt). 2006;15:1053–1060
  19. Wewalka G, Stary A, Bosse B, Duerr HE, Reimer K. Efficacy of povidone-iodine vaginal suppositories in the treatment of bacterial vaginosis. Dermatology. 2002;204(suppl 1):79–85
  20. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74:14–22
  21. Tokyol C, Aktepe OC, Cevrioglu AS, Altindis M, Dilek FH. Bacterial vaginosis: comparison of Pap smear and microbiological test results. Mod Pathol. 2004;17:857–860
  22. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med. 1996;5:593–596
  23. Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev. 2009;CD006055
  24. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194:1283–1289
  25. Alvarez-Olmos MI, Barousse MM, Rajan L, et al. Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity and to bacterial vaginosis. Sex Transm Dis. 2004;31:393–400
  26. Hellberg D, Nilsson S, Mardh PA. The diagnosis of bacterial vaginosis and vaginal flora changes. Arch Gynecol Obstet. 2001;265:11–15
  27. Thorsen P, Jensen IP, Jeune B, et al. Few microorganisms associated with bacterial vaginosis may constitute the pathologic core: a population-based microbiologic study among 3596 pregnant women. Am J Obstet Gynecol. 1998;178:580–587
  28. McLean NW, McGroarty JA. Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by lactobacilli in vitro. Appl Environ Microbiol. 1996;62:1089–1092
  29. Mastromarino P, Brigidi P, Macchia S, et al. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol. 2002;93:884–893
  30. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001;32:37–41
  31. Potter J. Should sexual partners of women with bacterial vaginosis receive treatment?. Br J Gen Pract. 1999;49:913–918
  32. Cook RL, Redondo-Lopez V, Schmitt C, Meriwether C, Sobel JD. Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol. 1992;30:870–877
  33. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect. 2004;80:8–11

 Supported by Nicar Laboratories, Inc, Blainville, Quebec, Canada. Sprim China Ltd. (Shanghai, China) designed and supervised the study.

 Cite this article as: Ya W, Reifer C, Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol 2010;203:120.e1-6.

PII: S0002-9378(10)00610-1

doi: 10.1016/j.ajog.2010.05.023

American Journal of Obstetrics & Gynecology
Volume 203, Issue 2 , Pages 120.e1-120.e6 , August 2010

Article Tools

* Image Usage & Resolution